Nuo Therapeutics Provides Update on Chapter 11 Bankruptcy Process and Proposed Plan of Reorganization

GAITHERSBURG, Md.--(BUSINESS WIRE)--Nuo Therapeutics, Inc. (OTC:NUOT) (“Nuo” or the “Company”), today announced that the United States Bankruptcy Court for the District of Delaware (the “Court”) entered an Order [Docket Entry No. 252] granting conditional approval to the Company’s Disclosure Statement for the First Amended Plan of Reorganization [Docket Entry No. 248] (the “Disclosure Statement”) in the ongoing Chapter 11 bankruptcy case (Case 16-10192) (the “Case”). The Court also approved an